Effectiveness of Aquamin® in Mitigating Halitosis

Part of paid clinical trials in Ann Arbor, Michigan.

Sponsor
University of Michigan
Study ID
NCT05058638
Phase
PHASE2
Status
Recruiting
Apply to this trial

Conditions

  • Halitosis
  • Healthy

Eligibility Criteria

Sex
ALL
Age
18 Years - 99 Years
Healthy Volunteers
Accepted

Interventions

  • Aquamin — DRUG
    Participants will take a 90-day supply of Aquamin®, 4 capsules per day; 2 to be taken in the morning and 2 in the evening (containing approximately 800 mg calcium/day).

Study Details

The purpose of this study is to assess whether Aquamin®, a multi-mineral natural product from red marine algae, can help reduce halitosis when taken for 90 days.

Key Dates

First listed
Sep 28, 2021
Start date
Aug 15, 2022
Status verified
Aug 2026
Primary completion
Dec 31, 2027
Completion
Dec 31, 2027

Study Design

Enrollment
25 participants (estimated)
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT

Arms

  • Experimental: Aquamin®

Primary Outcome Measure

Halitosis Associated Life-quality Test (HALT) questionnaire (modified) [ Time Frame: 90 days (post-intervention) ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
University of Michigan School of DentistryAnn ArborMichigan48109
Iwonka Eagle
[email protected]
734-615-8507

Find similar trials in Ann Arbor, MI

By research site
University of Michigan School of Dentistry· Ann Arbor, MI

Related Studies